产品编号:H294230
产品规格:100mg
产品价格:面议
| 标准品编号: | H294230 |
| 名称: | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxamide |
| 别名: | N-[(1S,2R)-1-[[[(1R)-1-[(3AS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-Phenyl-2-pyridinecarboxamide |
| CAS号: | 847494-64-8 |
| 分子式: | C₃₁H₄₂BN₃O₅ |
| 外观: | 白色固体 |
| 分子量: | 547.49 |
| 溶解度: | Chloroform, DCM, Methanol |
| 种类: | Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | N-[(1S,2R)-1-[[[(1R)-1-[(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborol-2-yl]-3-methylbutyl]amino]carbonyl]-2-hydroxypropyl]-6-phenyl-2-pyridinecarboxamide is an intermediate in the synthesis of Delanzomib (D230710), an orally active proteasome inhibitor. |
| 参考文献 | |